6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
2h ago	Regency Silver Appoints Private Equity Fund Manager Alejandro Sucre to Board of Directors
2h ago	Entrepreneur Universe Bright Group Reports First Quarter 2026 Financial Results
3h ago	Rio2 Reports First Quarter 2026 Financial Results and Operations Update
4h ago	Letter to the Shareholders
5h ago	ImagineAR Announces Non-Brokered Private Placement Financing

About

2.36EUR+0.03 +1.29%

Closed • Updated at 06:34 GMT+00:00

Market Cap$16.52M

Volume3.0K

Beta-0.05

RSI41.68

Gross Margin77.00%

Health TechnologyPharmaceuticals: Major

Biofrontera Ag — investor relations, events, news, and company updates on 6ix.

Latest News

Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Biofrontera Inc. Appoints George Jones as Chief Commercial Officer

Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment

Recent Videos

Biofrontera Company Webcast @ Lytham Partners 2026 Investor Healthcare Summit

Biofrontera Company Webcast @ Lytham Partners 2026 Investor Healthcare Summit

Jan 20, 2026

My Takeaway from Biofrontera's Nasdaq 8-K Filing

My Takeaway from Biofrontera's Nasdaq 8-K Filing

Jan 11, 2026

My Take on Biofrontera's Share Structure Shake-Up

My Take on Biofrontera's Share Structure Shake-Up

Sep 21, 2025

Biofrontera Q2 2025 Earnings Call

Biofrontera Q2 2025 Earnings Call

Aug 15, 2025

Community Chat

Ask AI